NCT01734889 - Taste and Palatability of Orfadin Suspension | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions

Hereditary Tyrosinemia, Type I

Interventions

DRUG

Nitisinone

Oral suspension

Trial Locations (7)

Hopital Necker, Paris

Universitätsklinikum Düsseldorf, Düsseldorf

Universitätsklinikum Heidelberg, Heidelberg

Klinikum der Universität München, München

Birmingham Children's Hospital, Birmingham

Evelina Children's Hospital, St Thomas' Hospital, London

St Mary's Hospital, Manchester